Veterinary Molecular Diagnostics Market
Veterinary Molecular Diagnostics Scope increasing, attributed to rising Companion Animals Ownership
Veterinary Molecular Diagnostics Market by Product Type, Species, Disease & Region- Forecast 2022 – 2032
Veterinary Molecular Diagnostics Market Snapshot (2022-2032)
[275 Pages Report] The global Veterinary Molecular Diagnostics market size is expected to be valued at US$ 182.1 Million in 2022. With the adoption of multiple testing panels, coupled with the growing consolidation in the veterinary diagnostics industry, the overall demand for Veterinary Molecular Diagnostics is projected to grow at a CAGR of 6.84% between 2022 and 2032, totaling around US$ 352.8 Million by 2032.
|
Data Points |
Key Statistics |
|
Veterinary Molecular Diagnostics Market Value 2022 |
US$ 182.1 Million |
|
Veterinary Molecular Diagnostics Market Projected Value (2032) |
US$ 352.8 Million |
|
Veterinary Molecular Diagnostics Market CAGR (2022-2032) |
6.84% |
Factors such as the growing pet animal population around the globe, increased animal health spending and advancements in veterinary molecular diagnostics are expected to propel the growth of the veterinary molecular diagnostics market over the analysis period.
Developments in the animal farming sector and changing societal attitude toward pet animals have resulted in an increased demand for fast and reliable diagnostic techniques. Molecular diagnostics possess the potential to address this growing demand.
As of 2018, more than 60% of the US population owned a pet/companion animal. There is an increasing trend of treating pets as family members, which has increased the healthcare demands for veterinary applications. The increasing pet population is one of the reasons for the rising health expenditure on animals, globally.
As per the estimates of the American Pet Products Association, the total American pet industry expenditure is expected to reach USD 75.38 billion by end 2019, up from USD 72.56 billion in 2018. The rise in animal health expenditure is expected to drive the growth of the veterinary molecular diagnostics market, as a significant portion of pet owners are expected to use advanced diagnostic modalities for animals, for various disease conditions.
Furthermore, there is an increase in the livestock population, owing to the huge demand for animal-derived products. This is expected to increase the demand for molecular diagnostic tests in the next coming years.
Let us know your requirement to get
100% FREE customization
Veterinary Molecular Diagnostics Demand Analysis (2017 to 2021) Vs Market Outlook (2022 to 2032)
The global demand for Veterinary Molecular Diagnostics is projected to increase at a CAGR of 6.84% during the forecast period between 2022 and 2032, reaching a total of US$ 352.8 Million in 2032, according to a report from Future Market Insights (FMI). In 2017, the market represented a revenue of US$ 118.7 Million. From 2017 to 2021, sales witnessed significant growth, registering a CAGR of 7.3%.
According to Future Market Insights, a market research and competitive intelligence provider, the Veterinary Molecular Diagnostics market was valued at US$ 168.7 Million in 2021.
Majority of the commercial products in the global veterinary molecular diagnostics market are available in the form of kits. These kits are predominantly based on PCR techniques and help in the screening of a family of related disorders.
The kits based on microarrays are steadily increasing their market share. Many products based on immune-assays are expected to receive marketing approval during the forecast period. There are several assays linked to pathogen and viruses’ detection, which are combined with the PCR techniques, such as Porcine Epidemic Diarrhea Virus (PEDv), Porcine Deltacoronavirus (PDCoV), and Transmissible Gastroenteritis Virus (TGEV).
Moreover, companies are involved in the development of the veterinary diagnostics kits and launching new products, this is likely to expand the segment growth. in September 2019, CEVA partners with Biotecon Diagnostics to introduce a real-time test kit to fight the growing problem of salmonella on pig farms.
Which Drivers underpin Veterinary Molecular Diagnostics Industry Expansion?
Untapped Emerging Markets to Accelerate the Market Growth
Emerging countries like India and China have robust livestock markets. According to the Livestock Production Statistics of India 2018, India is one of the largest milk producers (20.17% of the global production), followed by the US, China, Brazil, and Pakistan. According to the USDA Foreign Agricultural Service in 2017, China is the fourth-largest beef producer in the world. Beef production in China is estimated at 7.3 million metric tons. According to the FAO, China was the world’s largest hog producer and pork consumer. Pork consumption increased from 28.3 kg per person in 2012 to 34.2 kg per person in 2019.
The emerging economies are expected to become a focal point for the growth of the veterinary diagnostics market. The Asia Pacific, Middle Eastern, and Latin American regions are relatively untapped markets for companies compared to Europe and North America. Large poultry and dairy animal populations in these emerging markets are expected to drive the growth of the veterinary health market. Currently, the number of veterinarians in emerging markets is on the rise.
Further, many veterinary practices are adopting technologically advanced solutions commonly used by veterinarians in developed economies. Thus, with a surge in the companion animal population, growing demand for veterinary services from the livestock industry, and growing companion animal health expenditure, emerging countries across APAC and Latin America are expected to offer significant growth opportunities for the market.
Increasing Incidence of Transboundary and Zoonotic Diseases to Fuel the Market Growth
There are at least 30 major diseases in humans, that are directly transmitted through animals. Most human infections come from companion animals (such as dogs and cats) and livestock (such as pigs, chickens, cattle, goats, and camels). Some of the major zoonotic diseases transmitted from animals to humans are zoonotic gastrointestinal disease, leptospirosis, cysticercosis, zoonotic tuberculosis, and rabies.
The prevalence of transboundary diseases has also risen. For example, foot-and-mouth disease (FMD) was estimated to circulate in about 77% of the global livestock population in 2018 in countries across Africa, the Middle East, and Asia, as well as in a limited area of South America, with a morbidity rate of 100% (in susceptible cattle populations).
The global outbreak of COVID-19 caused by the SARS-CoV-2 virus has a zoonotic source. Based on phylogenetic analysis, bats appear to be the reservoir of the COVID-19 virus. Since there is usually limited close contact between humans and bats, it is more likely that the transmission of the virus to humans was through other animal species which were handled by humans. This intermediate animal host or zoonotic source could be a domestic animal, a wild animal, or a domesticated wild animal, and at present has not been identified. The COVID-19 pandemic has led to a drastic loss of human life worldwide and presents an unprecedented challenge to public health.
Find your sweet spots for generating winning opportunities in this market.
Talk to AnalystWhich Factors are limiting the Growth of Veterinary Molecular Diagnostics Market?
Shortage of Veterinary Practitioners in Developing Countries to Restrain the Market Growth
The global animal healthcare industry is marked by a shortage of skilled veterinarians and pathologists. This is particularly evident in the emerging markets across the APAC and Latin America, which show a huge gap in the demand and supply of veterinary professionals. According to the World Animal Health Information Database (2017), there were 180,821 veterinary professionals in India. The general norm is to have at least one veterinary doctor for every 5,000 animals.
According to the Vet Extension (2018), India’s total livestock population was 512.05 million; this translates into a requirement of 60,000 veterinarians catering to bovine animals alone. The demand will further increase if poultry, sheep, goats, pigs, and other animals are considered. Currently, the lack of skilled veterinarians and diagnostic infrastructure, especially in developing countries, is one of the major factors limiting the uptake of advanced diagnostic solutions among veterinarians.
High Cost Associated with the Rising Pet Care to Limit the Market Growth
In the last ten years, pet care costs have increased significantly. According to the APPA 2019 report, veterinary care is the second-highest source of spending in the pet care community. The US, for example, spent over USD 18.11 billion on veterinary care in 2018, a growth of 6.1% over the previous year. This is expected to reach USD 19.98 billion in 2019. PetMD also reported that low-to-medium pet care costs had reached USD 250 to USD 4,500 in veterinary practices, with a high-end procedure priced anywhere between USD 5,000 and USD 20,000.
According to the APPA National Pet Owners Survey 2019–2020, the average household in the US spent USD 212 on routine vet visits for dogs and USD 160 for cats in 2019. The average range of diagnostic revenue per clinical visit in the US was around USD 85?90 in 2020. This is mainly due to the availability of advanced monitoring, diagnostic, and therapeutic procedures in veterinary practices, which, though effective, come with high price tags. Advanced products and procedures play a significant role in treatments; however, the cost of materials and equipment used in these procedures is very high. For instance, diagnostic procedures for identifying sensitivity to antimicrobials, or the presence of infection using PCR or any other advanced technologies, are costlier than the actual treatment. Hence, pet owners and veterinarians are reluctant to invest so much for diagnostic purposes.
Country-wise Insights
Will US Continue Dominance in the Global Veterinary Molecular Diagnostics Market?
Rising Pet Adoption in the Region to Boost the Market Growth
The Veterinary Molecular Diagnostics Market in the US is expected to accumulate the highest market share of 34.6% in 2022. The United States is expected to dominate the market, attributed to factors, such as rising pet adoption and increasing per capita animal healthcare expenditure. In addition, the rise in the prevalence of various animal diseases and injuries is another major factor that is anticipated to fuel the market growth during the forecast period.
In addition, the presence of major players is one of the major factors contributing toward the dominance of the country in the global veterinary molecular diagnostics market. Moreover, rising awareness about animal wellness and increasing efforts by organizations to promote animal welfare activities in the US are further promoting the growth of the market in the nation.
Where does the growth of Veterinary Molecular Diagnostics Market in Germany stand?
High Usage of Superior-Quality Diagnostics Techniques in the Region
The Veterinary Molecular Diagnostics market in Germany is expected to accumulate a market share of 9.7% in 2022, and is expected to continue to maintain the trend over the forecast period as well.
Germany is the second-most lucrative country in the worldwide veterinary molecular diagnostics industry, behind the US. Increased government backing, high-quality diagnostic procedures, and the number of veterinary diagnostic centers are the major factors that are expected to escalate the growth of the veterinary molecular diagnostics industry grow in Germany.
Moreover, high usage of superior-quality diagnostics techniques, and active government support are some other factors that will propel the growth of the veterinary molecular diagnostics market in Germany during the forecast period.
How Will Growth of the Veterinary Molecular Diagnostics Market unfold in India?
Increasing Demand for Smart Grids in the Region
The Veterinary Molecular Diagnostics Market in India is expected to accumulate a market share value of 5.1% in 2022. India is expected to register significant growth over the forecast period owing to the increase in the number of diagnostic laboratories, government and private funding for veterinary health care activities, and rising awareness about veterinary molecular diagnostics in the region.
In addition, the rapidly rising animal population and high adoption of veterinary diagnostic products within the country are some other factors that are anticipated to fuel the growth of the veterinary molecular diagnostics market in India over the analysis period.
A unified Market Research Subscription Platform, built for today's disparate research needs.
Category-wise Insights
By Product Type, which Veterinary Molecular Diagnostics Category will remain prominent?
PCR Kits Segment of the Veterinary Molecular Diagnostics to beat Competition in Untiring Market
PCR Kits is estimated to account for the largest market share of 50.8% of the Veterinary Molecular Diagnostics market in 2022. Polymerase Chain Reaction (PCR) is widely used for molecular diagnosis in animals for the identification and detection of various pathogens. The traditional PCR techniques are rapidly being replaced by real-time PCR. It enables the rapid identification of pathogens and provides great accuracy.
The PCR kits segment is driving the market growth, owing to factors such as increasing need for quick and rapid result generating tests, growing research studies for development of new DNA and RNA-based therapies and others.
In addition, the increasing adulteration of food products and the growing need for accurate diagnosis are some other factors that are expected to fuel the growth of the PCR Kits segment of the veterinary molecular diagnostics market in the forthcoming years.
By Species Type, which Veterinary Molecular Diagnostics Category to dominate?
Livestock Animals Segment to Drive the Veterinary Molecular Diagnostics Market
Based on the Species Type, the Livestock Animals segment is expected to witness a significant growth of 71.0% in 2022, and the trend is expected to continue during the forecast period, attributed to the rising number of companion animals across the globe, the willingness of owners to spend more on their pets, the rising adoption of pet insurance, and the availability of cheaper and easy-to-use POC diagnostic tests for companion animals.
Moreover, infectious diseases cause loss of production capacity in livestock animals. Therefore, governments across the globe are heavily focusing on increasing awareness about these diseases by undertaking initiatives related to diagnosis. Also, governments are working with domestic and international partners to promote animal health products. These initiatives help educate decision-makers, regulatory agencies, reference laboratories, and other end-users regarding the importance of livestock diagnosis. These factors are also expected to fuel the segment’s growth in the near future.
The Start-Up Ecosystem: How key Players are opening Frontiers for Future Growth?
Veterinary Molecular Diagnostics Market such as Basepaws, Embark Veterinary, AnimalBiome, PetDx, Heska, Biotangents, Advanced Animal Diagnostics, and Volition, among others, are adopting various marketing strategies such as new product launches, geographical expansion, merger and acquisitions, partnerships and collaboration to identify the interest of potential buyers and create a larger customer base. For instance,
- Founded in 2017, Basepaws is a genetic testing service for cats. The company's service requires the customer to take a sample of the cat hair and mail it to the company's labs for sequencing. The company analyzes the DNA sequence and generates a report that includes the genetic make-up (mix of varieties). The company uses the genetic data to create a cross-species database of genotypic and phenotypic data which will be used to enable comparative medicine and translational research.
- Established in 2015, Embark Veterinary is a provider of DNA test kits for dogs that enable dog owners to provide better pet care. The test tracks more than 200,000 genetic markers. The test analyzes the dog's ancestry and provides an overview of both genetic disease risk and heritable traits so the owners can understand their dog’s health plans for the future. It also provides an app for dog owners to book an appointment and invite the Embark team to their homes to learn more about the test kit.
- Founded in 2017, the provider of animal microbiome-based diagnostics services for pet care, AnimalBiome allows the customers to send the sample through an assessment kit to extract and analyze the DNA to understand the pet's gut microbiome. They send an analysis report which also includes a gut health comparison tool and highlights any abnormal signs in the data. Their scientists can also talk to the pet's veterinarian about the necessary treatment options.
Who are the Leading Players in the Veterinary Molecular Diagnostics Market?
Prominent players in the Veterinary Molecular Diagnostics market are IDEXX Laboratories, Inc., Zoetis, Inc., Thermo Fisher Scientific Inc., NEOGEN Corporation, Bio-Rad Laboratories Inc., bioMérieux SA, Virbac, Agrolabo S.p.A., INDICAL BIOSCIENCE GmbH, Randox Laboratories Ltd., IDvet, Biopanda Reagents, Bionote, Inc., BioChek, Fassisi GmbH, Biogal Galed Labs, Alvedia, SKYER, Inc., and Shenzhen Bioeasy Biotechnology Co., Ltd., among others.
Recent Developments:
- In April 2021, INDICAL BIOSCIENCE GmbH (Germany) acquired Boehringer Ingelheim’s Svanova product portfolio which helped INDICAL widen its portfolio by adding 25 assays for livestock.
- In April 2021, BioChek (Netherlands) opened a new office in Johannesburg, South Africa.
- In January 2021, Heska Corporation (US) acquired Lacuna Diagnostics (US), this acquisition strengthened the company’s portfolio of point-of-care digital cytology technology and telemedicine services.
- In December 2020, NEOGEN Corporation (US) launched a preventative care DNA screening tool for detecting genetic diseases in dogs.
- In November 2020, NEOGEN Corporation (US) collaborated with Transnetyx Inc. (US), this partnership helped NEOGEN to increase its presence in the animal genomics and diagnostics market.
Report Scope
|
Report Attribute |
Details |
|
Growth Rate |
CAGR of 6.84% from 2022-2032 |
|
Market Value in 2022 |
US$ 182.1 Million |
|
Market Value in 2032 |
US$ 352.8 Million |
|
Base Year for Estimation |
2021 |
|
Historical Data |
2017-2021 |
|
Forecast Period |
2022-2032 |
|
Quantitative Units |
Revenue in US$ Million and CAGR from 2022-2032 |
|
Report Coverage |
Revenue Forecast, Company Ranking, Competitive Landscape, Growth Factors, Trends and Pricing Analysis |
|
Segments Covered |
|
|
Regions Covered |
|
|
Key Countries Profiled |
|
|
Key Companies Profiled |
|
Key Segments Covered in the Veterinary Molecular Diagnostics Industry Analysis
Veterinary Molecular Diagnostics Market by Product Type:
- Veterinary Molecular Diagnostics PCR Kits
- RT-PCR Kits
- RAPD-PCR Kits
- Veterinary Molecular Diagnostics INAAT Kits
- Veterinary Molecular Diagnostics Microarray Kits
- Veterinary Molecular Diagnostics DNA Sequencing Kits
Veterinary Molecular Diagnostics Market by Species Type:
- Veterinary Molecular Diagnostics for Livestock Animals
- Equine
- Porcine
- Poultry
- Cattle
- Aquatic
- Ovine
- Veterinary Molecular Diagnostics for Companion Animals
- Canine
- Feline
- Avian
Veterinary Molecular Diagnostics Market by Disease Type:
- Veterinary Molecular Diagnostics for Anaplasma spp.
- Veterinary Molecular Diagnostics for Ehrlichia spp.
- Veterinary Molecular Diagnostics for New Castle Disease
- Veterinary Molecular Diagnostics for Influenza
- Veterinary Molecular Diagnostics for Porcine Reproductive & Respiratory Syndrome (PRRS)
- Others
Veterinary Molecular Diagnostics Market by End-User:
- Veterinary Molecular Diagnostics for Veterinary Hospitals
- Veterinary Molecular Diagnostics for Clinical Laboratories
- Veterinary Molecular Diagnostics for Veterinary Research Institutes
Veterinary Molecular Diagnostics Market by Region:
- North America Veterinary Molecular Diagnostics Market
- Latin America Veterinary Molecular Diagnostics Market
- Europe Veterinary Molecular Diagnostics Market
- Asia Pacific Veterinary Molecular Diagnostics Market
- MEA Veterinary Molecular Diagnostics Market
Frequently Asked Questions
As of 2021, the market for Veterinary Molecular Diagnostics was valued at US$ 168.7 Mn, as per FMI
By 2022-end, sales of Veterinary Molecular Diagnostics closed at a value of US$ 182.1 Mn
From 2017 to 2021, Veterinary Molecular Diagnostics demand expanded at a CAGR of 7.3%
From 2022 to 2032, Veterinary Molecular Diagnostics sales are expected to flourish at a CAGR of 6.84%
According to FMI, what is the anticipated market value for Veterinary Molecular Diagnostics in 2032?
By 2032, the market value of Veterinary Molecular Diagnostics is expected to reach US$ 352.8 Mn.
By Product Type, the PCR Kits segment of the Veterinary Molecular Diagnostics constitutes the bulk of market share of 50.8% in 2022.
By Species Type, the Livestock Animals category of Veterinary Molecular Diagnostics dominates the market with a share of 71.0% in 2022.
Table of Content
1. Executive Summary
1.1. Market Overview
1.2. Market Analysis
1.3. FMI Analysis and Recommendations
1.4. Wheel of Fortune
2. Market Introduction
2.1. Market Definition
2.2. Market Taxonomy
3. Market Opportunity Analysis
3.1. Macro-Economic Factors
3.2. Opportunity Analysis
4. Market Background
4.1. List of Growth Hacking Manufacturers
4.2. Market Dynamics
4.2.1. Drivers
4.2.2. Restraints
4.2.3. Opportunity Analysis
4.2.4. Trends
4.3. Regulatory Scenario
5. Key Inclusions
5.1. Key Competition Mapping
6. North America Market Analysis 2017-2021 and Forecast 2022-2032
6.1. Introduction
6.2. Historical Market Size (US$ Mn) & Analysis by Country, 2017-2021
6.2.1. U.S.
6.2.2. Canada
6.3. Market Size (US$ Mn) & Forecast By Country, 2022-2032
6.4. Historical Market Size (US$ Mn) and Trend Analysis by Product, 2017-2021
6.4.1. PCR KITS
6.4.1.1. RAPD-PCR Kits
6.4.1.2. Real Time PCR Kits
6.4.2. INAAT KITS
6.4.3. Microarray Kits
6.4.4. DNA Sequencing Kits
6.5. Market Size (US$ Mn) and Forecast By Product, 2022-2032
6.6. Historical Market Size (US$ Mn) Trend Analysis by Disease Type, 2017-2021
6.6.1. Anaplasma spp.
6.6.2. Ehrlichia spp.
6.6.3. New Castle Disease
6.6.4. Influenza
6.6.5. Porcine Reproductive & Respiratory Syndrome (PRRS)
6.6.6. Others
6.7. Market Size (US$ Mn) Forecast By Disease Type, 2022-2032
6.8. Historical Market Size (US$ Mn) Trend Analysis by Species Type, 2017-2021
6.8.1. Companion Animals
6.8.1.1. Canine
6.8.1.2. Avian
6.8.1.3. Feline
6.8.2. Livestock Animals
6.8.2.1. Aquatic
6.8.2.2. Bovine
6.8.2.3. Porcine
6.8.2.4. Ovine/Caprine
6.8.2.5. Poultry
6.8.2.6. Equine
6.9. Market Size (US$ Mn) Forecast By Species Type, 2022-2032
6.10. Historical Market Size (US$ Mn) and Trend Analysis by End User, 2017-2021
6.10.1. Veterinary Hospitals
6.10.2. Clinical Laboratories
6.10.3. Veterinary Research Institutes
6.11. Market Size (US$ Mn) and Forecast By End User, 2022-2032
6.12. Drivers and Restraints: Impact Analysis
6.13. Market Attractiveness Analysis
6.13.1. By Country
6.13.2. By Product
6.13.3. By Disease Type
6.13.4. By Species Type
6.13.5. By End User
6.14. Key Market Participants – Intensity Mapping
7. Latin America Market Analysis 2017-2021 and Forecast 2022-2032
7.1. Introduction
7.2. Historical Market Size (US$ Mn) Trends and Analysis by Country, 2017-2021
7.2.1. Brazil
7.2.2. Mexico
7.2.3. Rest of Latin America
7.3. Market Size (US$ Mn) & Forecast By Country, 2022-2032
7.4. Historical Market Size (US$ Mn) and Trend Analysis by Product, 2017-2021
7.4.1. PCR KITS
7.4.1.1. RAPD-PCR Kits
7.4.1.2. Real Time PCR Kits
7.4.2. INAAT KITS
7.4.3. Microarray Kits
7.4.4. DNA Sequencing Kits
7.5. Market Size (US$ Mn) and Forecast By Product, 2022-2032
7.6. Historical Market Size (US$ Mn) Trend Analysis by Disease Type, 2017-2021
7.6.1. Anaplasma spp.
7.6.2. Ehrlichia spp.
7.6.3. New Castle Disease
7.6.4. Influenza
7.6.5. Porcine Reproductive & Respiratory Syndrome (PRRS)
7.6.6. Others
7.7. Market Size (US$ Mn) Forecast By Disease Type, 2022-2032
7.8. Historical Market Size (US$ Mn) Trend Analysis by Species Type, 2017-2021
7.8.1. Companion Animals
7.8.1.1. Canine
7.8.1.2. Avian
7.8.1.3. Feline
7.8.2. Livestock Animals
7.8.2.1. Aquatic
7.8.2.2. Bovine
7.8.2.3. Porcine
7.8.2.4. Ovine/Caprine
7.8.2.5. Poultry
7.8.2.6. Equine
7.9. Market Size (US$ Mn) Forecast By Species Type, 2022-2032
7.10. Historical Market Size (US$ Mn) and Trend Analysis by End User, 2017-2021
7.10.1. Veterinary Hospitals
7.10.2. Clinical Laboratories
7.10.3. Veterinary Research Institutes
7.11. Market Size (US$ Mn) and Forecast By End User, 2022-2032
7.12. Drivers and Restraints: Impact Analysis
7.13. Market Attractiveness Analysis
7.13.1. By Country
7.13.2. By Product
7.13.3. By Disease Type
7.13.4. By Species Type
7.13.5. By End User
7.14. Key Market Participants – Intensity Mapping
8. Europe Market Analysis 2017-2021 and Forecast 2022-2032
8.1. Introduction
8.2. Historical Market Size (US$ Mn) and Trend Analysis by Country, 2017-2021
8.2.1. Germany
8.2.2. U.K.
8.2.3. France
8.2.4. Italy
8.2.5. Spain
8.2.6. Russia
8.2.7. Rest of Europe
8.3. Market Size (US$ Mn) & Forecast By Country, 2022-2032
8.4. Historical Market Size (US$ Mn) and Trend Analysis by Product, 2017-2021
8.4.1. PCR KITS
8.4.1.1. RAPD-PCR Kits
8.4.1.2. Real Time PCR Kits
8.4.2. INAAT KITS
8.4.3. Microarray Kits
8.4.4. DNA Sequencing Kits
8.5. Market Size (US$ Mn) and Forecast By Product, 2022-2032
8.6. Historical Market Size (US$ Mn) Trend Analysis by Disease Type, 2017-2021
8.6.1. Anaplasma spp.
8.6.2. Ehrlichia spp.
8.6.3. New Castle Disease
8.6.4. Influenza
8.6.5. Porcine Reproductive & Respiratory Syndrome (PRRS)
8.6.6. Others
8.7. Market Size (US$ Mn) Forecast By Disease Type, 2022-2032
8.8. Historical Market Size (US$ Mn) Trend Analysis by Species Type, 2017-2021
8.8.1. Companion Animals
8.8.1.1. Canine
8.8.1.2. Avian
8.8.1.3. Feline
8.8.2. Livestock Animals
8.8.2.1. Aquatic
8.8.2.2. Bovine
8.8.2.3. Porcine
8.8.2.4. Ovine/Caprine
8.8.2.5. Poultry
8.8.2.6. Equine
8.9. Market Size (US$ Mn) Forecast By Species Type, 2022-2032
8.10. Historical Market Size (US$ Mn) and Trend Analysis by End User, 2017-2021
8.10.1. Veterinary Hospitals
8.10.2. Clinical Laboratories
8.10.3. Veterinary Research Institutes
8.11. Market Size (US$ Mn) and Forecast By End User, 2022-2032
8.12. Drivers and Restraints: Impact Analysis
8.13. Market Attractiveness Analysis
8.13.1. By Country
8.13.2. By Product
8.13.3. By Disease Type
8.13.4. By Species Type
8.13.5. By End User
8.14. Key Market Participants – Intensity Mapping
9. Asia Pacific Market Analysis 2017-2021 and Forecast 2022-2032
9.1. Introduction
9.2. Historical Market Size (US$ Mn) Trend Analysis by Country, 2017-2021
9.2.1. India
9.2.2. Australia and New Zealand
9.2.3. Rest of Asia Pacific
9.3. Market Size (US$ Mn) & Forecast By Country, 2022-2032
9.4. Historical Market Size (US$ Mn) and Trend Analysis by Product, 2017-2021
9.4.1. PCR KITS
9.4.1.1. RAPD-PCR Kits
9.4.1.2. Real Time PCR Kits
9.4.2. INAAT KITS
9.4.3. Microarray Kits
9.4.4. DNA Sequencing Kits
9.5. Market Size (US$ Mn) and Forecast By Product, 2022-2032
9.6. Historical Market Size (US$ Mn) Trend Analysis by Disease Type, 2017-2021
9.6.1. Anaplasma spp.
9.6.2. Ehrlichia spp.
9.6.3. New Castle Disease
9.6.4. Influenza
9.6.5. Porcine Reproductive & Respiratory Syndrome (PRRS)
9.6.6. Others
9.7. Market Size (US$ Mn) Forecast By Disease Type, 2022-2032
9.8. Historical Market Size (US$ Mn) Trend Analysis by Species Type, 2017-2021
9.8.1. Companion Animals
9.8.1.1. Canine
9.8.1.2. Avian
9.8.1.3. Feline
9.8.2. Livestock Animals
9.8.2.1. Aquatic
9.8.2.2. Bovine
9.8.2.3. Porcine
9.8.2.4. Ovine/Caprine
9.8.2.5. Poultry
9.8.2.6. Equine
9.9. Market Size (US$ Mn) Forecast By Species Type, 2022-2032
9.10. Historical Market Size (US$ Mn) and Trend Analysis by End User, 2017-2021
9.10.1. Veterinary Hospitals
9.10.2. Clinical Laboratories
9.10.3. Veterinary Research Institutes
9.11. Market Size (US$ Mn) and Forecast By End User, 2022-2032
9.12. Drivers and Restraints: Impact Analysis
9.13. Market Attractiveness Analysis
9.13.1. By Country
9.13.2. By Product
9.13.3. By Disease Type
9.13.4. By Species Type
9.13.5. By End User
9.14. Key Market Participants – Intensity Mapping
10. China Market Analysis 2017-2021 and Forecast 2022-2032
10.1. Introduction
10.2. Historical Market Size (US$ Mn) and Trend Analysis by Product, 2017-2021
10.2.1. PCR KITS
10.2.1.1. RAPD-PCR Kits
10.2.1.2. Real Time PCR Kits
10.2.2. INAAT KITS
10.2.3. Microarray Kits
10.2.4. DNA Sequencing Kits
10.3. Market Size (US$ Mn) and Forecast By Product, 2022-2032
10.4. Historical Market Size (US$ Mn) Trend Analysis by Disease Type, 2017-2021
10.4.1. Anaplasma spp.
10.4.2. Ehrlichia spp.
10.4.3. New Castle Disease
10.4.4. Influenza
10.4.5. Porcine Reproductive & Respiratory Syndrome (PRRS)
10.4.6. Others
10.5. Market Size (US$ Mn) Forecast By Disease Type, 2022-2032
10.6. Historical Market Size (US$ Mn) Trend Analysis by Species Type, 2017-2021
10.6.1. Companion Animals
10.6.1.1. Canine
10.6.1.2. Avian
10.6.1.3. Feline
10.6.2. Livestock Animals
10.6.2.1. Aquatic
10.6.2.2. Bovine
10.6.2.3. Porcine
10.6.2.4. Ovine/Caprine
10.6.2.5. Poultry
10.6.2.6. Equine
10.7. Market Size (US$ Mn) Forecast By Species Type, 2022-2032
10.8. Historical Market Size (US$ Mn) and Trend Analysis by End User, 2017-2021
10.8.1. Veterinary Hospitals
10.8.2. Clinical Laboratories
10.8.3. Veterinary Research Institutes
10.9. Market Size (US$ Mn) and Forecast By End User, 2022-2032
10.10. Drivers and Restraints: Impact Analysis
10.11. Market Attractiveness Analysis
10.11.1. By Product
10.11.2. By Disease Type
10.11.3. By Species Type
10.11.4. By End User
10.12. Key Market Participants – Intensity Mapping
11. Middle East & Africa Market Analysis 2017-2021 and Forecast 2022-2032
11.1. Introduction
11.2. Historical Market Size (US$ Mn) and Trend Analysis by Country, 2017-2021
11.2.1. GCC Countries
11.2.2. South Africa
11.2.3. Rest of MEA
11.3. Market Size (US$ Mn) & Forecast By Country, 2022-2032
11.4. Historical Market Size (US$ Mn) and Trend Analysis by Product, 2017-2021
11.4.1. PCR KITS
11.4.1.1. RAPD-PCR Kits
11.4.1.2. Real Time PCR Kits
11.4.2. INAAT KITS
11.4.3. Microarray Kits
11.4.4. DNA Sequencing Kits
11.5. Market Size (US$ Mn) and Forecast By Product, 2022-2032
11.6. Historical Market Size (US$ Mn) Trend Analysis by Disease Type, 2017-2021
11.6.1. Anaplasma spp.
11.6.2. Ehrlichia spp.
11.6.3. New Castle Disease
11.6.4. Influenza
11.6.5. Porcine Reproductive & Respiratory Syndrome (PRRS)
11.6.6. Others
11.7. Market Size (US$ Mn) Forecast By Disease Type, 2022-2032
11.8. Historical Market Size (US$ Mn) Trend Analysis by Species Type, 2017-2021
11.8.1. Companion Animals
11.8.1.1. Canine
11.8.1.2. Avian
11.8.1.3. Feline
11.8.2. Livestock Animals
11.8.2.1. Aquatic
11.8.2.2. Bovine
11.8.2.3. Porcine
11.8.2.4. Ovine/Caprine
11.8.2.5. Poultry
11.8.2.6. Equine
11.9. Market Size (US$ Mn) Forecast By Species Type, 2022-2032
11.10. Historical Market Size (US$ Mn) and Trend Analysis by End User, 2017-2021
11.10.1. Veterinary Hospitals
11.10.2. Clinical Laboratories
11.10.3. Veterinary Research Institutes
11.11. Market Size (US$ Mn) and Forecast By End User, 2022-2032
11.12. Drivers and Restraints: Impact Analysis
11.13. Market Attractiveness Analysis
11.13.1. By Country
11.13.2. By Product
11.13.3. By Disease Type
11.13.4. By Species Type
11.13.5. By End User
11.14. Key Market Participants – Intensity Mapping
12. Forecast Factors: Relevance and Impact
13. Forecast Assumptions
14. Competition Analysis
14.1. Competition Dashboard
14.2. Company Deep Dive
14.2.1. BioMerieux SA
14.2.1.1. Overview
14.2.1.2. Product and Application Portfolio
14.2.1.3. Production Footprint
14.2.1.4. Sales Footprint
14.2.1.5. Channel Footprint
14.2.1.6. Strategy
14.2.1.6.1. Marketing Strategy
14.2.1.6.2. Product Strategy
14.2.1.6.3. Channel Strategy
14.2.2. IDEXX Laboratories, Inc.
14.2.2.1. Overview
14.2.2.2. Product and Application Portfolio
14.2.2.3. Production Footprint
14.2.2.4. Sales Footprint
14.2.2.5. Channel Footprint
14.2.2.6. Strategy
14.2.2.6.1. Marketing Strategy
14.2.2.6.2. Product Strategy
14.2.2.6.3. Channel Strategy
14.2.3. Thermo Fisher Scientific Inc.
14.2.3.1. Overview
14.2.3.2. Product and Application Portfolio
14.2.3.3. Production Footprint
14.2.3.4. Sales Footprint
14.2.3.5. Channel Footprint
14.2.3.6. Strategy
14.2.3.6.1. Marketing Strategy
14.2.3.6.2. Product Strategy
14.2.3.6.3. Channel Strategy
14.2.4. Qiagen N.V.
14.2.4.1. Overview
14.2.4.2. Product and Application Portfolio
14.2.4.3. Production Footprint
14.2.4.4. Sales Footprint
14.2.4.5. Channel Footprint
14.2.4.6. Strategy
14.2.4.6.1. Marketing Strategy
14.2.4.6.2. Product Strategy
14.2.4.6.3. Channel Strategy
14.2.5. Neogene Corporation
14.2.5.1. Overview
14.2.5.2. Product and Application Portfolio
14.2.5.3. Production Footprint
14.2.5.4. Sales Footprint
14.2.5.5. Channel Footprint
14.2.5.6. Strategy
14.2.5.6.1. Marketing Strategy
14.2.5.6.2. Product Strategy
14.2.5.6.3. Channel Strategy
14.2.6. ID.Vet
14.2.6.1. Overview
14.2.6.2. Product and Application Portfolio
14.2.6.3. Production Footprint
14.2.6.4. Sales Footprint
14.2.6.5. Channel Footprint
14.2.6.6. Strategy
14.2.6.6.1. Marketing Strategy
14.2.6.6.2. Product Strategy
14.2.6.6.3. Channel Strategy
14.2.7. INDICAL BIOSCIENCE GmbH
14.2.7.1. Overview
14.2.7.2. Product and Application Portfolio
14.2.7.3. Production Footprint
14.2.7.4. Sales Footprint
14.2.7.5. Channel Footprint
14.2.7.6. Strategy
14.2.7.6.1. Marketing Strategy
14.2.7.6.2. Product Strategy
14.2.7.6.3. Channel Strategy
14.2.8. Veterinary Molecular Diagnostics, Inc.
14.2.8.1. Overview
14.2.8.2. Product and Application Portfolio
14.2.8.3. Production Footprint
14.2.8.4. Sales Footprint
14.2.8.5. Channel Footprint
14.2.8.6. Strategy
14.2.8.6.1. Marketing Strategy
14.2.8.6.2. Product Strategy
14.2.8.6.3. Channel Strategy
15. Global Market Analysis 2017-2021 and Forecast 2022-2032, By Region
15.1. Introduction/Key Findings
15.2. Historical Market Size (US$ Mn) Trend Analysis by Region, 2017-2021
15.3. Market Size (US$ Mn) Forecast By Region, 2022-2032
15.3.1. North America
15.3.2. Latin America
15.3.3. Europe
15.3.4. Asia Pacific Excluding China
15.3.5. Middle East & Africa
15.3.6. China
15.4. Market Attractiveness Analysis by Region
16. Global Analysis 2017-2021 and Forecast 2022-2032, By Product
16.1. Introduction/Key Findings
16.2. Historical Market Size (US$ Mn) and Trend Analysis by Product, 2017-2021
16.2.1. PCR KITS
16.2.1.1. RAPD-PCR Kits
16.2.1.2. Real Time PCR Kits
16.2.2. INAAT KITS
16.2.3. Microarray Kits
16.2.4. DNA Sequencing Kits
16.3. Market Size (US$ Mn) and Forecast By Product, 2022-2032
16.4. Market Attractiveness Analysis by Product
17. Global Market Analysis 2017-2021 and Forecast 2022-2032, By Disease Type
17.1. Introduction/Key Findings
17.2. Historical Market Size (US$ Mn) Trend Analysis by Disease Type, 2017-2021
17.2.1. Anaplasma spp.
17.2.2. Ehrlichia spp.
17.2.3. New Castle Disease
17.2.4. Influenza
17.2.5. Porcine Reproductive & Respiratory Syndrome (PRRS)
17.2.6. Others
17.3. Market Size (US$ Mn) Forecast By Disease Type, 2022-2032
17.4. Market Attractiveness Analysis by Disease Type
18. Global Market Analysis 2017-2021 and Forecast 2022-2032, By Species Type
18.1. Introduction/Key Findings
18.2. Historical Market Size (US$ Mn) Trend Analysis by Species Type, 2017-2021
18.2.1. Companion Animals
18.2.1.1. Canine
18.2.1.2. Avian
18.2.1.3. Feline
18.2.2. Livestock Animals
18.2.2.1. Aquatic
18.2.2.2. Bovine
18.2.2.3. Porcine
18.2.2.4. Ovine/Caprine
18.2.2.5. Poultry
18.2.2.6. Equine
18.3. Market Size (US$ Mn) Forecast By Species Type, 2022-2032
18.4. Market Attractiveness Analysis by Species Type
19. Global Market Analysis 2017-2021 and Forecast 2022-2032, By End User
19.1. Introduction/Key Findings
19.2. Historical Market Size (US$ Mn) and Trend Analysis by End User, 2017-2021
19.2.1. Veterinary Hospitals
19.2.2. Clinical Laboratories
19.2.3. Veterinary Research Institutes
19.3. Market Size (US$ Mn) and Forecast By End User, 2022-2032
19.4. Market Attractiveness Analysis by End User
20. Global Market Analysis 2017-2021 and Forecast 2022-2032
20.1. Market Value Share Analysis by All Segment
20.2. Y-o-Y Growth Analysis by All Segment
20.3. Absolute $ Opportunity
21. Assumptions and Acronyms Used
22. Research Methodology
Let us know your requirement to get
100% FREE customization
List of Tables
Table 01: Global Key Company and Product Mapping
Table 02: North America Market size (US$ Mn) Analysis 2017-2021 and Forecast 2022-2032, By Country
Table 03: North America Market size (US$ Mn) Analysis 2017-2021 and Forecast 2022-2032, By Product
Table 04: North America Market size (US$ Mn) Analysis 2017-2021 and Forecast 2022-2032, By Species
Table 05: North America Market size (US$ Mn) Analysis 2017-2021 and Forecast 2022-2032, By Disease Type
Table 06: North America Market size (US$ Mn) Analysis 2017-2021 and Forecast 2022-2032, By End User
Table 07: Latin America Market size (US$ Mn) Analysis 2017-2021 and Forecast 2022-2032, By Country
Table 08: Latin America Market size (US$ Mn) Analysis 2017-2021 and Forecast 2022-2032, By Product
Table 09: Latin America Market size (US$ Mn) Analysis 2017-2021 and Forecast 2022-2032, By Species
Table 10: Latin America Market size (US$ Mn) Analysis 2017-2021 and Forecast 2022-2032, By Disease Type
Table 11: Latin America Market size (US$ Mn) Analysis 2017-2021 and Forecast 2022-2032, By End User
Table 12: Europe Market size (US$ Mn) Analysis 2017-2021 and Forecast 2022-2032, By Country
Table 13: Europe Market size (US$ Mn) Analysis 2017-2021 and Forecast 2022-2032, By Product
Table 14: Europe Market size (US$ Mn) Analysis 2017-2021 and Forecast 2022-2032, By Species
Table 15: Europe Market size (US$ Mn) Analysis 2017-2021 and Forecast 2022-2032, By Disease Type
Table 16: Europe Market size (US$ Mn) Analysis 2017-2021 and Forecast 2022-2032, By End User
Table 17: APEC Market size (US$ Mn) Analysis 2017-2021 and Forecast 2022-2032, By Country
Table 18: APEC Market size (US$ Mn) Analysis 2017-2021 and Forecast 2022-2032, By Product
Table 19: APEC Market size (US$ Mn) Analysis 2017-2021 and Forecast 2022-2032, By Species
Table 20: APEC Market size (US$ Mn) Analysis 2017-2021 and Forecast 2022-2032, By Disease Type
Table 21: APEC Market size (US$ Mn) Analysis 2017-2021 and Forecast 2022-2032, By End User
Table 22: China Market size (US$ Mn) Analysis 2017-2021 and Forecast 2022-2032, By Product
Table 23: China Market size (US$ Mn) Analysis 2017-2021 and Forecast 2022-2032, By Species
Table 24: China Market size (US$ Mn) Analysis 2017-2021 and Forecast 2022-2032, By Disease Type
Table 25: China Market size (US$ Mn) Analysis 2017-2021 and Forecast 2022-2032, By End User
Table 26: MEA Market size (US$ Mn) Analysis 2017-2021 and Forecast 2022-2032, By Country
Table 27: MEA Market size (US$ Mn) Analysis 2017-2021 and Forecast 2022-2032, By Product
Table 28: MEA Market size (US$ Mn) Analysis 2017-2021 and Forecast 2022-2032, By Species
Table 29: MEA Market size (US$ Mn) Analysis 2017-2021 and Forecast 2022-2032, By Disease Type
Table 30: MEA Market size (US$ Mn) Analysis 2017-2021 and Forecast 2022-2032, By End User
Table 31: Global Market size (US$ Mn) Analysis 2017-2021 and Forecast 2022-2032, By Region
Table 32: Global Market size (US$ Mn) Analysis 2017-2021 and Forecast 2022-2032, By Product Type
Table 33: Global Market size (US$ Mn) Analysis 2017-2021 and Forecast 2022-2032, By Species
Table 34: Global Market size (US$ Mn) Analysis 2017-2021 and Forecast 2022-2032, By Disease Type
Table 35: Global Market size (US$ Mn) Analysis 2017-2021 and Forecast 2022-2032, By End User
Find your sweet spots for generating winning opportunities in this market.
Talk to AnalystList of Charts
Figure 01: Global Market Value Share 2022E, By Product Type
Figure 02: Global Market Revenue Opportunity Analysis, By Region 2022-2032
Figure 03: Global Veterinary Diagnostics Market Value Share 2022A and 2022E, By Species Type
Figure 04: Global Market, 2022A
Figure 05: Estimated Breakdown of Vet Diagnostics Industry Expenditure (US$ Bn), 2021
Figure 06: Total U.S. Pet Industry Expenditures (US$ Bn), 2021
Figure 07: U.S. Consumer Spending (US$ Bn) on Veterinary Care
Figure 08: Global Vet PCR Diagnostic Kit Average Price, 2017-2021
Figure 09: North America Market Value Share, By Product Type (2022A)
Figure 10: North America Market Value Share, By Disease Type (2022A)
Figure 11: North America Market Value Share (2022A), By Species & End User
Figure 12: North America Market Value Share (2022A), By Country
Figure 13: North America Market size (US$ Mn) Analysis, 2017-2021
Figure 14: North America Market Value (US$ Mn) & Y-o-Y Growth (%), 2022-2032
Figure 15: U.S. Market size (US$ Mn) Analysis, 2017-2021
Figure 16: U.S. Market Value (US$ Mn) & Y-o-Y Growth (%), 2022-2032
Figure 17: Canada Market size (US$ Mn) Analysis, 2017-2021
Figure 18: Canada Market Value (US$ Mn) & Y-o-Y Growth (%), 2022-2032
Figure 19: North America PCR Kits Market size (US$ Mn) Analysis, 2017-2021
Figure 20: North America PCR Kits Market Value (US$ Mn) & Y-o-Y Growth (%), 2022-2032
Figure 21: North America INAAT Kits Market size (US$ Mn) Analysis, 2017-2021
Figure 22: North America INAAT Kits Market Value (US$ Mn) & Y-o-Y Growth (%), 2022-2032
Figure 23: North America Microarray Kits Market size (US$ Mn) Analysis, 2017-2021
Figure 24: North America Microarray Kits Market Value (US$ Mn) & Y-o-Y Growth (%), 2022-2032
Figure 25: North America DNA Sequencing Kits Market size (US$ Mn) Analysis, 2017-2021
Figure 26: North America DNA Sequencing Kits Market Value (US$ Mn) & Y-o-Y Growth (%), 2022-2032
Figure 27: North America Market size (US$ Mn) Analysis, By Livestock Animals, and 2017-2021
Figure 28: North America Market Value (US$ Mn) & Y-o-Y Growth (%), By Livestock Animals, 2022-2032
Figure 29: North America Market size (US$ Mn) Analysis, By Companion animals, 2017-2021
Figure 30: North America Market Value (US$ Mn) & Y-o-Y Growth (%), By Companion animals, 2022-2032
Figure 31: North America Market Attractiveness Analysis, By Product Type
Figure 32: North America Market Attractiveness Analysis, By Species
Figure 33: North America Market Attractiveness Analysis, By Disease Type
Figure 34: North America Market Attractiveness Analysis, By End User
Figure 35: North America Market Attractiveness Analysis, By Country
Figure 36: Latin America Market Value Share, By Product Type (2022A)
Figure 37: Latin America Market Value Share, By Disease Type (2022A)
Figure 38: Latin America Market Value Share (2022A), By Species & End User
Figure 39: Latin America Market Value Share (2022A), By Country
Figure 40: Latin America Market size (US$ Mn) Analysis, 2017-2021
Figure 41: Latin America Market Value (US$ Mn) & Y-o-Y Growth (%), 2022-2032
Figure 42: Brazil Market size (US$ Mn) Analysis, 2017-2021
Figure 43: Brazil Market Value (US$ Mn) & Y-o-Y Growth (%), 2022-2032
Figure 44: Mexico Market size (US$ Mn) Analysis, 2017-2021
Figure 45: Mexico Market Value (US$ Mn) & Y-o-Y Growth (%), 2022-2032
Figure 46: Rest of Latin America Market Value (US$ Mn) & Y-o-Y Growth (%), 2022-2032
Figure 47: Rest of Latin America Market Value (US$ Mn) & Y-o-Y Growth (%), 2022-2032
Figure 48: Latin America PCR Kits Market size (US$ Mn) Analysis, 2017-2021
Figure 49: Latin America PCR Kits Market Value (US$ Mn) & Y-o-Y Growth (%), 2022-2032
Figure 50: Latin America INAAT Kits Market size (US$ Mn) Analysis, 2017-2021
Figure 51: Latin America INAAT Kits Market Value (US$ Mn) & Y-o-Y Growth (%), 2022-2032
Figure 52: Latin America Microarray Kits Market size (US$ Mn) Analysis, 2017-2021
Figure 53: Latin America Microarray Kits Market Value (US$ Mn) & Y-o-Y Growth (%), 2022-2032
Figure 54: Latin America DNA Sequencing Kits Market size (US$ Mn) Analysis, 2017-2021
Figure 55: Latin America DNA Sequencing Kits Market Value (US$ Mn) & Y-o-Y Growth (%), 2022-2032
Figure 56: Latin America Market size (US$ Mn) Analysis, By Livestock Animals, and 2017-2021
Figure 57: Latin America Market Value (US$ Mn) & Y-o-Y Growth (%), By Livestock Animals, 2022-2032
Figure 58: Latin America Market size (US$ Mn) Analysis, By Companion animals, 2017-2021
Figure 59: Latin America Market Value (US$ Mn) & Y-o-Y Growth (%), By Companion animals, 2022-2032
Figure 60: Latin America Market Attractiveness Analysis, By Product Type
Figure 61: Latin America Market Attractiveness Analysis, By Species
Figure 62: Latin America Market Attractiveness Analysis, By Disease Type
Figure 63: Latin America Market Attractiveness Analysis, By End User
Figure 64: Latin America Market Attractiveness Analysis, By Country
Figure 65: Europe Market Value Share, By Product Type (2022A)
Figure 66: Europe Market Value Share, By Disease Type (2022A)
Figure 67: Europe Market Value Share (2022A), By Species & End User
Figure 68: Europe Market Value Share (2022A), By Country
Figure 69: Europe Market size (US$ Mn) Analysis, 2017-2021
Figure 70: Europe Market Value (US$ Mn) & Y-o-Y Growth (%), 2022-2032
Figure 71: Germany Market size (US$ Mn) Analysis, 2017-2021
Figure 72: Germany Market Value (US$ Mn) & Y-o-Y Growth (%), 2022-2032
Figure 73: UK Market size (US$ Mn) Analysis, 2017-2021
Figure 74: UK Market Value (US$ Mn) & Y-o-Y Growth (%), 2022-2032
Figure 75: France Market size (US$ Mn) Analysis, 2017-2021
Figure 76: France Market Value (US$ Mn) & Y-o-Y Growth (%), 2022-2032
Figure 77: Italy Market size (US$ Mn) Analysis, 2017-2021
Figure 78: Italy Market Value (US$ Mn) & Y-o-Y Growth (%), 2022-2032
Figure 79: Spain Market size (US$ Mn) Analysis, 2017-2021
Figure 80: Spain Market Value (US$ Mn) & Y-o-Y Growth (%), 2022-2032
Figure 81: Russia Market size (US$ Mn) Analysis, 2017-2021
Figure 82: Russia Market Value (US$ Mn) & Y-o-Y Growth (%), 2022-2032
Figure 83: Rest of Europe Market Value (US$ Mn) & Y-o-Y Growth (%), 2022-2032
Figure 84: Rest of Europe Market Value (US$ Mn) & Y-o-Y Growth (%), 2022-2032
Figure 85: Europe PCR Kits Market size (US$ Mn) Analysis, 2017-2021
Figure 86: Europe PCR Kits Market Value (US$ Mn) & Y-o-Y Growth (%), 2022-2032
Figure 87: Europe INAAT Kits Market size (US$ Mn) Analysis, 2017-2021
Figure 88: Europe INAAT Kits Market Value (US$ Mn) & Y-o-Y Growth (%), 2022-2032
Figure 89: Europe Microarray Kits Market size (US$ Mn) Analysis, 2017-2021
Figure 90: Europe Microarray Kits Market Value (US$ Mn) & Y-o-Y Growth (%), 2022-2032
Figure 91: Europe DNA Sequencing Kits Market size (US$ Mn) Analysis, 2017-2021
Figure 92: Europe DNA Sequencing Kits Market Value (US$ Mn) & Y-o-Y Growth (%), 2022-2032
Figure 93: Europe Market size (US$ Mn) Analysis, By Livestock Animals, and 2017-2021
Figure 94: Europe Market Value (US$ Mn) & Y-o-Y Growth (%), By Livestock Animals, 2022-2032
Figure 95: Europe Market size (US$ Mn) Analysis, By Companion animals, 2017-2021
Figure 96: Europe Market Value (US$ Mn) & Y-o-Y Growth (%), By Companion animals, 2022-2032
Figure 97: Europe Market Attractiveness Analysis, By Product Type
Figure 98: Europe Market Attractiveness Analysis, By Species
Figure 99: Europe Market Attractiveness Analysis, By Disease Type
Figure 100: Europe Market Attractiveness Analysis, By End User
Figure 101: Europe Market Attractiveness Analysis, By Country
Figure 102: APEC Market Value Share, By Product Type (2022A)
Figure 103: APEC Market Value Share, By Disease Type (2022A)
Figure 104: APEC Market Value Share (2022A), By Species & End User
Figure 105: APEC Market Value Share (2022A), By Country
Figure 106: APEC Market size (US$ Mn) Analysis, 2017-2021
Figure 107: APEC Market Value (US$ Mn) & Y-o-Y Growth (%), 2022-2032
Figure 108: India Market size (US$ Mn) Analysis, 2017-2021
Figure 109: India Market Value (US$ Mn) & Y-o-Y Growth (%), 2022-2032
Figure 110: Australia & New Zealand Market size (US$ Mn) Analysis, 2017-2021
Figure 111: Australia & New Zealand Market Value (US$ Mn) & Y-o-Y Growth (%), 2022-2032
Figure 112: Rest of APEC Market Value (US$ Mn) & Y-o-Y Growth (%), 2022-2032
Figure 113: Rest of APEC Market Value (US$ Mn) & Y-o-Y Growth (%), 2022-2032
Figure 114: APEC PCR Kits Market size (US$ Mn) Analysis, 2017-2021
Figure 115: APEC PCR Kits Market Value (US$ Mn) & Y-o-Y Growth (%), 2022-2032
Figure 116: APEC INAAT Kits Market size (US$ Mn) Analysis, 2017-2021
Figure 117: APEC INAAT Kits Market Value (US$ Mn) & Y-o-Y Growth (%), 2022-2032
Figure 118: APEC Microarray Kits Market size (US$ Mn) Analysis, 2017-2021
Figure 119: APEC Microarray Kits Market Value (US$ Mn) & Y-o-Y Growth (%), 2022-2032
Figure 120: APEC DNA Sequencing Kits Market size (US$ Mn) Analysis, 2017-2021
Figure 121: APEC DNA Sequencing Kits Market Value (US$ Mn) & Y-o-Y Growth (%), 2022-2032
Figure 122: APEC Market size (US$ Mn) Analysis, By Livestock Animals, and 2017-2021
Figure 123: APEC Market Value (US$ Mn) & Y-o-Y Growth (%), By Livestock Animals, 2022-2032
Figure 124: APEC Market size (US$ Mn) Analysis, By Companion animals, 2017-2021
Figure 125: APEC Market Value (US$ Mn) & Y-o-Y Growth (%), By Companion animals, 2022-2032
Figure 126: APEC Market Attractiveness Analysis, By Product Type
Figure 127: APEC Market Attractiveness Analysis, By Species
Figure 128: APEC Market Attractiveness Analysis, By Disease Type
Figure 129: APEC Market Attractiveness Analysis, By End User
Figure 130: APEC Market Attractiveness Analysis, By Country
Figure 131: China Market Value Share, By Product Type (2022A)
Figure 132: China Market Value Share, By Disease Type (2022A)
Figure 133: China Market Value Share (2022A), By Species & End User
Figure 134: China Market size (US$ Mn) Analysis, 2017-2021
Figure 135: China Market Value (US$ Mn) & Y-o-Y Growth (%), 2022-2032
Figure 136: China PCR Kits Market size (US$ Mn) Analysis, 2017-2021
Figure 137: China PCR Kits Market Value (US$ Mn) & Y-o-Y Growth (%), 2022-2032
Figure 138: China INAAT Kits Market size (US$ Mn) Analysis, 2017-2021
Figure 139: China INAAT Kits Market Value (US$ Mn) & Y-o-Y Growth (%), 2022-2032
Figure 140: China Microarray Kits Market size (US$ Mn) Analysis, 2017-2021
Figure 141: China Microarray Kits Market Value (US$ Mn) & Y-o-Y Growth (%), 2022-2032
Figure 142: China DNA Sequencing Kits Market size (US$ Mn) Analysis, 2017-2021
Figure 143: China DNA Sequencing Kits Market Value (US$ Mn) & Y-o-Y Growth (%), 2022-2032
Figure 144: China Market size (US$ Mn) Analysis, By Livestock Animals, and 2017-2021
Figure 145: China Market Value (US$ Mn) & Y-o-Y Growth (%), By Livestock Animals, 2022-2032
Figure 146: China Market size (US$ Mn) Analysis, By Companion animals, 2017-2021
Figure 147: China Market Value (US$ Mn) & Y-o-Y Growth (%), By Companion animals, 2022-2032
Figure 148: China Market Attractiveness Analysis, By Product Type
Figure 149: China Market Attractiveness Analysis, By Species
Figure 150: China Market Attractiveness Analysis, By Disease Type
Figure 151: China Market Attractiveness Analysis, By End User
Figure 152: MEA Market Value Share, By Product Type (2022A)
Figure 153: MEA Market Value Share, By Disease Type (2022A)
Figure 154: MEA Market Value Share (2022A), By Species & End User
Figure 155: MEA Market Value Share (2022A), By Country
Figure 156: MEA Market size (US$ Mn) Analysis, 2017-2021
Figure 157: MEA Market Value (US$ Mn) & Y-o-Y Growth (%), 2022-2032
Figure 158: GCC Countries Market size (US$ Mn) Analysis, 2017-2021
Figure 159: GCC Countries Market Value (US$ Mn) & Y-o-Y Growth (%), 2022-2032
Figure 160: South Africa Market size (US$ Mn) Analysis, 2017-2021
Figure 161: South Africa Market Value (US$ Mn) & Y-o-Y Growth (%), 2022-2032
Figure 162: Rest of MEA Market Value (US$ Mn) & Y-o-Y Growth (%), 2022-2032
Figure 163: Rest of MEA Market Value (US$ Mn) & Y-o-Y Growth (%), 2022-2032
Figure 164: MEA PCR Kits Market size (US$ Mn) Analysis, 2017-2021
Figure 165: MEA PCR Kits Market Value (US$ Mn) & Y-o-Y Growth (%), 2022-2032
Figure 166: MEA INAAT Kits Market size (US$ Mn) Analysis, 2017-2021
Figure 167: MEA INAAT Kits Market Value (US$ Mn) & Y-o-Y Growth (%), 2022-2032
Figure 168: MEA Microarray Kits Market size (US$ Mn) Analysis, 2017-2021
Figure 169: MEA Microarray Kits Market Value (US$ Mn) & Y-o-Y Growth (%), 2022-2032
Figure 170: MEA DNA Sequencing Kits Market size (US$ Mn) Analysis, 2017-2021
Figure 171: MEA DNA Sequencing Kits Market Value (US$ Mn) & Y-o-Y Growth (%), 2022-2032
Figure 172: MEA Market size (US$ Mn) Analysis, By Livestock Animals, and 2017-2021
Figure 173: MEA Market Value (US$ Mn) & Y-o-Y Growth (%), By Livestock Animals, 2022-2032
Figure 174: MEA Market size (US$ Mn) Analysis, By Companion animals, 2017-2021
Figure 175: MEA Market Value (US$ Mn) & Y-o-Y Growth (%), By Companion animals, 2022-2032
Figure 176: MEA Market Attractiveness Analysis, By Product Type
Figure 177: MEA Market Attractiveness Analysis, By Species
Figure 178: MEA Market Attractiveness Analysis, By Disease Type
Figure 179: MEA Market Attractiveness Analysis, By End User
Figure 180: MEA Market Attractiveness Analysis, By Country
Figure 181: Global Market Share Analysis (%) By Region, 2022 & 2028
Figure 182: Global Market Y-o-Y Growth (%) By Region, 2022-2032
Figure 183: Global Market Attractiveness Analysis by Region, 2022-2032
Figure 184: Global Market Share Analysis (%) By Product Type, 2022 & 2028
Figure 185: Global Market Y-o-Y Growth (%) By Product Type, 2022-2032
Figure 186: Global Market Attractiveness Analysis by Product Type, 2022-2032
Figure 187: Global Market Share Analysis (%) By Species, 2022 & 2028
Figure 188: Global Market Y-o-Y Growth (%) By Species, 2022-2032
Figure 189: Global Market Attractiveness Analysis by Species, 2022-2032
Figure 190: Global Market Share Analysis (%) By Disease Type, 2022 & 2028
Figure 191: Global Market Y-o-Y Growth (%) By Disease Type, 2022-2032
Figure 192: Global Market Attractiveness Analysis by Disease Type, 2022-2032
Figure 193: Global Market Share Analysis (%) By End User, 2022 & 2028
Figure 194: Global Market Y-o-Y Growth (%) By End User, 2022-2032
Figure 195: Global Market Attractiveness Analysis by End User, 2022-2032
Figure 196: Global Market Value Analysis and Forecast, 2022-2032 (US$ Mn)
Figure 197: Global Market Value (US$ Mn), 2017-2021
Figure 198: Global Market Absolute $ Opportunity (US$ Mn), 2022-2032
Need specific information?
Request CustomizationExplore Healthcare Insights
View Reports
